Reducing Aβ1-42 production using PKCε, the most important enzyme involving in AD, can lead to the inhibition of GSK-3β and consequently, the reduction of tau phosphorylation and neurofibrillary tangles. The gene discussed is MAPT; the disease is Alzheimer disease.